Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00652964
Recruitment Status : Unknown
Verified November 2012 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : April 4, 2008
Last Update Posted : November 8, 2012
Sponsor:
Information provided by (Responsible Party):
National Taiwan University Hospital

Brief Summary:
Detect the PHOX2B Mutation-confirmed congenital central hypoventilation syndrome

Condition or disease Intervention/treatment
Central Alveolar Hypoventilation Syndrome Device: CPAP

Detailed Description:

Background: Congenital central hypoventilation syndrome (CCHS) is characterized by compromised chemo-reflexes that results in hypoventilation during sleep. Recently, a heterozygous PHOX2B gene mutation was identified in CCHS. This report was made to increase physicians' awareness of this rare disease.

Methods: A Chinese family of CCHS with presentations from newborn to adulthood and genetic analysis confirming the PHOX2B mutation was analyzed. After identifying central hypoventilation in an adult male (index case), clinical evaluation was performed on the complete family, which consisted of the parents, five siblings, and five offsprings. In addition, pulmonary function test, overnight polysomnography, arterial blood gas, and hypercapnia ventilatory response, and genetic screening for PHOX2B gene mutations were performed on living family members.


Layout table for study information
Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Family-Based
Time Perspective: Cross-Sectional
Official Title: PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood
Study Start Date : September 2009
Estimated Primary Completion Date : December 2012
Estimated Study Completion Date : December 2012


Group/Cohort Intervention/treatment
Observation
a family of congenital central hypoventilation syndrome
Device: CPAP
CPAP treatment for patients with congenital central hypoventilation syndrome




Primary Outcome Measures :
  1. respiratory failure [ Time Frame: cross sectional observation ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
A Chinese family of CCHS with presentations from newborn to adulthood and genetic analysis confirming the PHOX2B mutation was analyzed. After identifying central hypoventilation in an adult male (index case), clinical evaluation was performed on the complete family, which consisted of the parents, five siblings, and five offsprings. In addition, pulmonary function test, overnight polysomnography, arterial blood gas, and hypercapnia ventilatory response, and genetic screening for PHOX2B gene mutations were performed on living family members.
Criteria

Inclusion Criteria:

  • Members of familiar congenital central hypoventilation syndrome

Exclusion Criteria:

  • Refuse to participate study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00652964


Contacts
Layout table for location contacts
Contact: Peilin Lee, M.D. +886-2-23562905 leepeilin@ntu.edu.tw

Locations
Layout table for location information
Taiwan
Naitonal Taiwan University Hospital Recruiting
Taipei, Taiwan, Taipei
Contact: Peilin Lee, M.D.    +886-2-23562905    leepeilin@ntu.edu.tw   
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Peilin Lee, M.D National Taiwan University Hospital

Layout table for additonal information
Responsible Party: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00652964     History of Changes
Other Study ID Numbers: 200801064R
First Posted: April 4, 2008    Key Record Dates
Last Update Posted: November 8, 2012
Last Verified: November 2012
Keywords provided by National Taiwan University Hospital:
sleep apnea, PHOX2B, hypoventilation, polysomnography
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypoventilation
Sleep Apnea, Central
Syndrome
Disease
Pathologic Processes
Respiratory Insufficiency
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Apnea Syndromes
Apnea
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases